Vaccine-derived poliovirus from long term excretors and the end game of polio eradication

Biologicals

Volumn 34, Issue 2, 2006, Pages 117-122

  Martín, Javier ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Adaptive changes; Excretion; Immunodeficiency; Molecular evolution; Vaccine derived polioviruses; Virus shedding

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ANTIGENICITY; ARTICLE; HUMAN; INFECTION CONTROL; NUCLEOTIDE SEQUENCE; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY; VIRULENCE; VIRUS CARRIER; VIRUS EXCRETION;

CHILD; HUMANS; POLIOMYELITIS; POLIOVIRUS; POPULATION SURVEILLANCE; VIRUS SHEDDING;

POLIOVIRUS;

EID: 33646812569     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2006.02.005     Document Type: Article

References (12)

1. MacCallum F.O. Hypogammaglobulinaemia in the United Kingdom. VII. The role of humoral antibodies in protection against and recovery from bacterial and virus infections in hypogammaglobulinaemia. Spec Rep Ser Med Res Counc (G B) 310 (1971) 72-85
2. Minor P.D. The molecular biology of poliovaccines. J Gen Virol 73 Pt 12 (1992) 3065-3077
3. MacLennan C., Dunn G., Huissoon A.P., Kumararatne D.S., Martin J., O'Leary P., et al. Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet 363 9420 (2004) 1509-1513
4. Misbah S.A., Lawrence P.A., Kurtz J.B., and Chapel H.M. Prolonged faecal excretion of poliovirus in a nurse with common variable hypogammaglobulinaemia. Postgrad Med J 67 785 (1991) 301-303
5. Buttinelli G., Donati V., Fiore S., Marturano J., Plebani A., Balestri P., et al. Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis. J Gen Virol 84 Pt 5 (2003) 1215-1221
6. Bellmunt A., May G., Zell R., Pring-Akerblom P., Verhagen W., and Heim A. Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient. Virology 265 2 (1999) 178-184
7. Kew O.M., Sutter R.W., Nottay B.K., McDonough M.J., Prevots D.R., Quick L., et al. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol 36 10 (1998) 2893-2899
8. Martin J., Dunn G., Hull R., Patel V., and Minor P.D. Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol 74 7 (2000) 3001-3010
9. Kew O.M., Mulders M.N., Lipskaya G.Y., da Silva E.E., and Pallansch M.A. Molecular epidemiology of polioviruses. Semin Virol 6 (1995) 401-414
10. Martin J., Odoom K., Tuite G., Dunn G., Hopewell N., Cooper G., et al. Long-term excretion of vaccine-derived poliovirus by a healthy child. J Virol 78 24 (2004) 13839-13847
11. Halsey N.A., Pinto J., Espinosa-Rosales F., Faure-Fontenla M.A., da Silva E., Khan A.J., et al. Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil and the United Kingdom. Bull World Health Organ 82 1 (2004) 3-8
12. Kew O., Morris-Glasgow V., Landaverde M., Burns C., Shaw J., Garib Z., et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 14 (2002) 14